SVRA · Savara Inc · Metrics
$4.76
+0.13 (+2.81%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$951.28M
Shares
205.46M
Volume · Oct 20
4.42M
Avg daily vol (3M)
1.94M
SVRA metrics
68 of 122 screener metrics currently available.
Market overview
2 metricsShare price
$4.76
Market cap
$951.28M
Price action
20 metricsPrice change (1W)
-0.4%
Price change (30D)
-12.7%
Price change (3M)
-18.5%
Price change (6M)
-9.8%
Price change (YTD)
-21.1%
Price change (1Y)
+15.8%
Trailing year
Price change (5Y)
+280.8%
52-week high
$6.94
52-week low
$3.95
Change from 52-week high
-31.4%
Change from 52-week low
+20.5%
Annualized volatility
53.0%
Annualized volatility (3M)
45.0%
Beta
1.3
RSI (14D)
43.8
Price vs SMA 50
-8.4%
Price vs SMA 200
-12.4%
Avg volume (3M)
1.94M
Relative volume
2.3
Average dollar volume
$10.16M
Company
3 metricsSector
Healthcare
Industry
Biotechnology
Shares outstanding
205.46M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
805,990.9×
reciprocal yield 0.0%
EV / EBITDA
—
EV / EBIT
—
P / sales
951,279.9×
reciprocal yield 0.0%
P / book
6.6
reciprocal yield 15.1%
FCF yield
-11.6%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-14.6%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2020-08-06
Profitability
9 metricsGross margin
—
Operating margin
-19,182.9%
Trailing 12 months
Net margin
-19,305.4%
Gross profit (TTM)
—
Operating profit (TTM)
−$143.63M
Net income (TTM)
−$139.31M
Trailing 12 months
Diluted EPS (TTM)
$-0.58
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-100.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$1,000
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+17.2%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
+36.6%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-97.0%
Return on assets
-72.5%
Debt / equity
0.2
Current ratio
10.1
EBITDA (TTM)
−$143.55M
Free cash flow (TTM)
−$110.66M
Quick ratio
10.1
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$142.93M
Latest balance sheet
Cash & equivalents
$41.80M
Total assets
$192.14M
Total debt
$30.11M
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$110.38M
Capital expenditures (TTM)
$280,000
R&D (TTM)
$86.84M
SG&A (TTM)
$8.09M
Stock compensation (TTM)
$27.27M
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
9 metrics13F filers
182
13F filer change QoQ
-5
Institutional ownership
105.8%
Conviction holders (share of 13F filers)
3.3%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+2.3%
Holder tenure
11.4
Price vs estimated holder cost
+59.7%
Ownership (registered funds)
1 metricsIndex-fund ownership
12.4%
Short interest
3 metricsShort interest
21.2%
Latest settlement · 17.2 days to cover
Days to cover
17.2d
Short-squeeze score
69 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—